Prakt. lékáren. 2010; 6(5): 244-249

New medicinal substances in extemporaneous prescription, part 3 - Clotrimazole

PharmDr.Jan Hašek1, PharmDr.Zbyněk Sklenář, Ph.D.2
1 Lékárna U Matky Boží, Doksy
2 Vyšší odborná škola zdravotnická, Plzeň

The present article provides information on the properties and use of clotrimazole in the treatment of mycotic diseases of the skin

and mucosae. The introduction summarizes the basic galenical properties and possibilities of formulating clotrimazole in medicinal

products; next, examples of formulas are presented which are suitable for pharmacy compounding. Combinations of clotrimazole

with other drugs are frequently ordered by physicians in prescriptions for customized medications which, however, have so far been

preparable only when using proprietary creams containing clotrimazole. The use of the pharmaceutical substance allows not only to

prescribe and then to prepare a combined dermatological external drug with a specific stability as well as to preserve the therapeutic

concentration of medicinal substances, but also to prepare solutions for oral and aural administration which are currently not available

in the form of proprietary medicinal products.

Keywords: clotrimazole, antifungal drugs, customized preparation, stability, tinea, onychomycoses

Published: October 19, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hašek J, Sklenář Z. New medicinal substances in extemporaneous prescription, part 3 - Clotrimazole. Praktické lékárenství. 2010;6(5):244-249.
Download citation

References

  1. Sklenář Z, Hašek J. Nové léčivé látky v magistraliter receptuře I - Nystatin. Prakt Lékáren 2010; 6(1): 30-35.
  2. Deutscher Arzneimittel-Codex (DAC) 2007/Neues Rezeptur-Formularium (NRF). Band I-III. Pharmazeutischen Laboratorium des NRF. Eschborn: Govi-Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2007.
  3. Buchta V, Slezák R, Špaček J, et al. Současné možnosti léčby kožních a slizničních mykóz. Klin farmakol farmac 2008; 22(2): 72-79.
  4. Kolektiv autorů. Remedia Compendium. 4. přeprac. a rozšíř. vyd. Praha: Panax Co, s.r.o, 2009: 544 s.
  5. Borovanský A, Csöllei J. Farmaceutická chemie (Farmakochemie). VI. díl - léčiva s účinkem antiinfekčním a antiparazitárním (2. část). 1. vyd. Brno: Veterinární a farmaceutická univerzita Brno, 2003: 135 s.
  6. Štork J, et al. Dermatovenerologie. 1. vyd. Praha: Galén a Karolinum, 2008: 502 s.
  7. Rezepturhinweise NRF - Neues Rezeptur-Formularium, Pharmazeutische Zeitung, Govi-Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2006.
  8. Wirkstoffdossiers für externe dermatologische Rezepturen, Gesellschaft für Dermopharmazie 2009. Dostupné v pdf souboru na http://www.gd-online.de/german/fgruppen/magistral/wirkstoffdossiers.htm, cit. [5. 8. 2010].
  9. Wolf G, Süverkrüp R. Rezepturen Probleme Erkennen, Lösen, Vermeiden. Stuttgart: Deutscher Apotheker Verlag Stuttgart, 2002: 192 s.
  10. Český lékopis 2005. 1. vyd. Praha: Grada Publishing, a.s., 2005: 3264 s.
  11. Sklenář Z. Magistraliter receptura v dermatologii. Praha: Galén, 2009: 441 s.
  12. Garbe C, Reimann H. Dermatologische Rezepturen. 2. přeprac. vyd. Stuttgart: Gregor Thieme Verlag, 2005: 297 s. Go to original source...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.